Aenova Group

Starnberg, Germany Founded: 2008 • Age: 18 yrs
CDMO services for pharmaceuticals, medical devices, and nutraceuticals are provided.
Annual revenue - Latest available
Total funding - 2 rounds
Employees - Tracked headcount
Investors 3 Known backers
Products 2 Services tracked
Competitors 10 Brand Intelligence

About Aenova Group

Aenova Group is a company based in Starnberg (Germany) founded in 2008. Aenova Group has completed 1 acquisition, including Temmler Group. Aenova Group offers products and services including Contract Manufacturing and Drug Development. Aenova Group operates in a competitive market with competitors including Akums, Jubilant Life Sciences, Recipharm, Unither and Nectar Lifesciences, among others.

  • Headquarter Starnberg, Germany
  • Sectors
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
  • Legal Name Aenova Holding Gmbh
Operational Areas
Healthcare → Healthcare Services & Infrastructure Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Latest Funding Round
    $112.9 M (USD), Debt – Conventional

    Mar 03, 2020

  • Investors
  • Employee Count
    Not available
  • Investments & Acquisitions
  • Acquired by

    & 1 more

    (Apr 24, 2024)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Aenova Group

Aenova Group offers a comprehensive portfolio of products and services, including Contract Manufacturing and Drug Development.

Product name locked
Category locked
Primary

Offers production of pharmaceutical products for clients

Product name locked
Category locked
Locked

Provides technology and development for healthcare solutions

People of Aenova Group

Headcount 1000-5000
Employee Profiles 102
Board Members and Advisors 12
Employee Profiles
People
Andrea Peloso
QC Technical Support
People
Luca Cenciarini
HR Employee Relations & Development
People
Tim Bauer
SVP, Human Resources
People
Nikla Rizzato
Ms&t - Lifecycle Project Manager

Unlock access to complete

Board Members and Advisors
people
Bernd Schmider
Board Member

Unlock access to complete

Funding Insights of Aenova Group

Investors in Aenova Group

Aenova Group has secured backing from 3 investors, including venture fund investors. Prominent investors backing the company include Bridgepoint Capital, BC Partners and Pemberton Asset Management.

All
Venture Fund
Investor Description Founded Year Domain Location
Pemberton Asset Management is recognized as a leading European private credit manager.
Locked Locked Locked
Middle-market businesses up to €1 billion are acquired pan-Europe.
Locked Locked Locked
Diversified alternative assets are managed through investment strategies.
Locked Locked Locked
Premium access

Investor details for Aenova Group

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Aenova Group

Aenova Group has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Temmler Group.

Investments
Premium access

Investment portfolio details for Aenova Group

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Acquisitions
Company Name Description Domain Location Founded Year Amount
CMO for solid, semi-solid and liquid dosage forms
Locked Locked 1917 Locked
Premium access

Complete acquisition details for Aenova Group

Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.

  • Transaction dates
  • Acquired stakes
  • Disclosed values
  • Domains and locations

Verified entity values are shown only after access is granted.

Financial Statements - Aenova Group

Premium access

Detailed financials for Aenova Group

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Aenova Group Comparisons

Aenova Group Primary company
Description
CDMO services for pharmaceuticals, medical devices, and nutr...
Location
Starnberg, Germany
Founded Year
2008
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
Not available
Premium access

Peer comparison for Aenova Group

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Aenova Group

Aenova Group operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Akums, Jubilant Life Sciences, Recipharm, Unither and Nectar Lifesciences, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
CDMO focusing on spectrum of dosage forms and therapeutic segments
Locked Locked Locked
Company offering a suite of R&D and manufacturing services for small molecules and generics
Locked Locked Locked
Pharmaceutical development and manufacturing services are offered contractually.
Locked Locked Locked
Contract development and manufacturing organization for proprietary and generic drugs
Locked Locked Locked
Cephalosporin APIs and generic formulations are manufactured.
Locked Locked Locked
CDMO with a focus on early phase drug product development
Premium access

Detailed competitors of Aenova Group

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Aenova Group

Premium access

Complete news archive for Aenova Group

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Aenova Group

Aenova Group was founded in 2008.

Aenova Group is headquartered in Starnberg, Germany. It is registered at Starnberg, Bavaria, Germany.

Aenova Group was founded in 2008 in Starnberg, Germany, and functions as a contract development and manufacturing organization in the pharmaceutical sector. Operations span 27 locations across nine European countries, Asia, and the USA. Services encompass product development, formulation, clinical trial material preparation, trial coordination, dossier preparation, production, research and development, analytical development, and supply chain management for solid, semi-solid, and liquid dosage forms in medicinal and food supplements.

Aenova Group's top competitors include Jubilant Life Sciences, Akums and Nectar Lifesciences.

Aenova Group offers Contract Manufacturing and Drug Development.

Aenova Group has made 1 acquisition, including Temmler Group.

Aenova Group has 3 investors. Key investors include Bridgepoint Capital, BC Partners, and Pemberton Asset Management.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available